Background: In the past, the diagnosis of ductal carcinoma in situ (OCIS) was rare, but today the incidence of OCIS has become much more frequem, panicularly in patients who underwent mammographic screening. 1be management of patients with DCIS has become a major clinical dilemma. It has become increasingly difficult to justify the routine use of mastectomy for patients with nCIS, because its natural history is uncertain and breast·conserving therapy (BCI') is currently used for the treatment of many patients with invasive breast cancer. Methods: To investigate the incidence, clinicopathologic features and the outcome of treatment of DCIS and microinvasive carcinoma (MIC), the medical records and pathology slides of 91 patients with DCIS and MlC who had been treated at KCCH between 1983 and 1996 were reviewed retrospectively. Median follow·up period was 69.4 (4~158) months, Results: The results were as
